Polymorphism of xenobiotic-metabolizing genes and breast cancer susceptibility in North Indian Women

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 5, 2011, Pages 343-349

  Singh, Virendra ^a   Upadhyay, Ghanshyam ^a   Rastogi, Neeraj ^b   Singh, Kalpana ^c   Singh, Mahendra Pratap ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^c S N MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ADULT; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INDIA; MAJOR CLINICAL STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BREAST NEOPLASMS; CYTOCHROME P-450 CYP1A2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; METABOLIC DETOXICATION, DRUG; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); POLYMORPHISM, SINGLE NUCLEOTIDE; XENOBIOTICS;

EID: 79956087499     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0197     Document Type: Article

References (35)

1. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
2. Bradlow HL, Sepkovic DW (2004) Steroids as procarcinogenic agents. Ann NY Acad Sci 1028:216-232. (Pubitemid 40361824)
3. Brockstedt U, Krajinovic M, Richer C, et al. (2002) Analyses of bulky DNA adduct levels in human breast tissue and genetic polymorphisms of cytochromes P450 (CYPs), myeloperoxidase (MPO), quinone oxidoreductase (NQO1), and glutathione S-transferases (GSTs). Mutat Res 516:41-47. (Pubitemid 34415499)
4. Cavalieri E, Frenkel K, Liehr JG, et al. (2000) Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monogr 27:75-93.
5. Cavalieri EL, Stack DE, Devanesan PD, et al. (1997) Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 94:10937-10942. (Pubitemid 27430839)
6. Fowke JH, Shu XO, Dai Q, et al. (2004) Oral contraceptive use and breast cancer risk: modification by NAD(P)H:quinine oxoreductase (NQO1) genetic polymorphisms. Cancer Epidemiol Biomarkers Prev 13:1308-1315. (Pubitemid 39071554)
7. Gong X, Kole L, Iskander K, et al. (2007) NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53. Cancer Res 67:5380-5388. (Pubitemid 46997278)
8. Hamajima N, Matsuo K, Iwata H, et al. (2002) NAD(P)H: quinine oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int J Clin Oncol 7:103-108. (Pubitemid 34538454)
9. Hayes CL, Spink DC, Spink BC, et al. (1996) 17-beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 93:9776-9781. (Pubitemid 26296685)
10. Hong CC, Ambrosone CB, Ahn J, et al. (2007) Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 16:1784-1794. (Pubitemid 47450508)
11. Huang JD, Guo WC, Lai MD, et al. (1999) Detection of a novel cytochrome P-450 1A2 polymorphism (F21L) in Chinese. Drug Metab Dispos 27:98-101.
12. Kemp TJ, Causton HC, Clerk A (2003) Changes in gene expression induced by H2O2 in cardiac myocytes. Biochem Biophys Res Commun 307:416-421. (Pubitemid 36818887)
13. Le Marchand L, Donlon T, Kolonel LN, et al. (2005) Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 14: 1998-2003. (Pubitemid 41161214)
14. Le Marchand L, Franke AA, Custer L, et al. (1997) Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherol. Pharmacogenetics 7:11-19. (Pubitemid 27153315)
15. Lee YY, Westphal AH, de Haan LH, et al. (2005) Human NAD(P)H:quinone oxidoreductase inhibition by flavonoids in living cells. Free Radic Biol Med 39:257-265. (Pubitemid 40814551)
16. Liehr JG (2000) Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 21:40-54.
17. Long JR, Cai Q, Shu XO, et al. (2007) Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival. Pharmacogenet Genomics 17:331-338. (Pubitemid 46608540)
18. Long JR, Egan KM, Dunning L, et al. (2006) Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk. Pharmacogenet Genomics 16:237-243.
19. Lyn-Cook BD, Yan-Sanders Y, Moore S, et al. (2006) Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) inpancreatic tissues from smokers and pancreatic adenocarcinomas: a potential biomarker of early damage in the pancreas. Cell Biol Toxicol 22:73-80. (Pubitemid 43376191)
20. Menzel HJ, Sarmanova J, Soucek P, et al. (2004) Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations. Br J Cancer 90:1989-1994. (Pubitemid 38746342)
21. Miller SA, Dykes DD, Polesky HF (1998) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
22. Mitrunen K, Hirvonen A (2003) Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 544:9-41. (Pubitemid 36903202)
23. Moran JL, Siegel D, Ross D (1999) A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc Natl Acad Sci USA 96:8150-8155. (Pubitemid 29328423)
24. Rauth AM, Goldberg Z, Misra V (1997) DT-diaphorase: possible roles in cancer chemotherapy and carcinogenesis. Oncol Res 9:339-349. (Pubitemid 127825988)
25. Rebbeck TR, Godwin AK, Buetow KH (1996) Variability in loss of constitutional heterozygosity across loci and among individuals: association with candidate genes in ductal breast carcinoma. Mol Carcinog 17:117-125. (Pubitemid 26408186)
26. Sachse C, Bhambra U, Smith G, et al. (2003) Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism. Br J Clin Pharmacol 55:68-76. (Pubitemid 36110841)
27. Sangrajrang S, Sato Y, Sakamoto H, et al. (2009) Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. Int J Cancer 125:837-843.
28. Sarmanova J, Susova S, Gut I, et al. (2004) Breast cancer: role of polymorphisms in biotransformation enzymes. Eur J Hum Genet 12:848-854. (Pubitemid 39406070)
29. Singh V, Rastogi N, Mathur N, et al. (2008) Association of polymorphism in MDM-2 and p53 genes with breast cancer risk in Indian women. Ann Epidemiol 18:48-57. (Pubitemid 350184342)
30. Singh V, Rastogi N, Sinha A, et al. (2007) A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women. Breast Cancer Res Treat 101:73-81. (Pubitemid 47555325)
31. Tsuchiya Y, Nakajima M, Yokoi T (2005) Cytochrome P450- mediated metabolism of estrogens and its regulation in human. Cancer Lett 227:115-124. (Pubitemid 41174580)
32. Yadav S, Singhal NK, Singh V, et al. (2009) Association of single nucleotide polymorphisms in CYP1B1 and COMT genes with breast cancer susceptibility in Indian women. Dis Markers 27:203-210.
33. Zhang J, Schulz WA, Li Y, et al. (2003) Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. Carcinogenesis 24:905-909. (Pubitemid 36748907)
34. Zhu BT, Conney AH (1998a) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19:1-27. (Pubitemid 28376821)
35. Zhu BT, Conney AH (1998b) Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res 58:2269-2277 (Pubitemid 28252677)